Search Results - N. Belousova
- Showing 1 - 20 results of 24
- Go to Next Page
-
1
Application of fuzzy modeling in the evaluation of crisis state of enterprises by M. N. Belousova, A. A. Dashkov
Published 2019-04-01
Article -
2
-
3
-
4
Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases by O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin
Published 2018-09-01
Article -
5
-
6
-
7
ANALYSIS AND FORECASTING THE DYNAMICS OF ADVERTISING BOTS ACTIVITY by Yu. V. Trushina, M. N. Belousova, E. Yu. Belova, V. A. Belousov
Published 2020-12-01
Article -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Advantages of long-term combination pharmacotherapy with a beta-blocker and eplerenone in patients with ST-segment elevation acute coronary syndrome by O. A. Osipova, V. P. Mikhin, A. I. Golovin, O. N. Belousova, D. N. Perutsky, P. K. Alferov, S. L. Konstantinov
Published 2022-07-01
Article -
16
-
17
Dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke receiving beta-blockers by O. A. Osipova, E. V. Gosteva, O. N. Belousova, S. G. Gorelik, N. I. Klyushnikov, Yu. A. Lykov, A. N. Khachaturov, V. V. Bukatov
Published 2022-01-01
Article -
18
Effect of angiotensin II receptor blocker therapy on markers of fibrosis and immune inflammation in hypertensive patients with chronic kidney disease after ischemic stroke by O. A. Osipova, E. V. Gosteva, O. N. Belousova, T. P. Golivets, J. Yu. Chefranova, Yu. A. Lykov, A. N. Khachaturov, N. I. Golovina
Published 2021-11-01
Article -
19
Changes of myocardial fibrosis markers with the use of beta-blockers and mineralocorticoid receptor antagonists in patients with heart failure with mid-range ejection fraction of i... by O. A. Osipova, E. V. Gosteva, T. P. Golivets, O. N. Belousova, O. A. Zemlyansky, M. V. Pokrovsky, A. I. Golovin, N. V. Grigorenko, A. A. Merezhko
Published 2021-11-01
Article -
20